Drug Shortage Report for SANDOZ CIPROFLOXACIN
| Report ID | 188611 |
| Drug Identification Number | 02248757 |
| Brand name | SANDOZ CIPROFLOXACIN |
| Common or Proper name | CIPROFLOXACIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100FCT |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-31 |
| Estimated end date | 2023-04-21 |
| Actual end date | 2023-04-17 |
| Shortage status | Resolved |
| Updated date | 2023-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-04-18 | French | Compare |
| v3 | 2023-04-18 | English | Compare |
| v2 | 2023-04-04 | French | Compare |
| v1 | 2023-04-04 | English | Compare |
Showing 1 to 4 of 4